Scan to downloadChordia Therapeutics,Inc (190A) Earnings Releases & Disclosures
| Date | Type | Title | Files |
|---|---|---|---|
| 2026-10-23 | — | Announcement Regarding the Reduction of Capital Reserve and Appropriation of Surplus | |
| 2026-10-15 | Presentation Materials | Fiscal year ended August 2026 Financial Results Presentation | |
| 2026-10-15 | Earnings Release | Non-consolidated Financial Results for the Fiscal Year Ended August 31, 2026 [Japanese GAAP] | |
| 2026-09-30 | — | Announcement Regarding AMED Grant Award for rogocekib (CTX-712) | |
| 2026-09-24 | — | Announcement Regarding Completion of Patient Enrollment in the Initial Expansion Cohort of rogocekib | |
| 2026-08-25 | — | Announcement of Orphan Drug Designation in Japan for rogocekib for Relapsed or Refractory AML | |
| 2026-07-28 | — | Announcement Regarding the Review Status of Orphan Drug Designation for Rogocekib, a CLK Inhibitor | |
| 2026-07-17 | — | Notice of Receipt of Grant | |
| 2026-07-15 | Earnings Release | Non-consolidated Financial Results for the Nine Months Ended May 31 2026 [Japanese GAAP] |
TDnet keeps only 31 days; this site accumulates daily and cannot backfill earlier disclosures.